Literature DB >> 11038121

5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.

T Chandy1, G S Das, G H Rao.   

Abstract

The development of injectable microspheres for anticancer drug delivery into the brain is a major challenge. The possibility of entrapping 5-fluorouracil (5-FU) in chitosan coated monodisperse biodegradable microspheres with a mean diameter of 10-25 um was demonstrated. An emulsion of 5-FU (in water) and polylactic acid (PLA) dissolved in acetone-dichloromethane mixture was poured into an aqueous solution of chitosan (or poly-vinyl alcohol) with stirring using a high-speed homogenizer, for the formation of microspheres. 5-FU recovery in microspheres ranged from 44-66% depending on the polymer and emulsification systems used for the preparation. Scanning electron microscopy revealed that the chitosan coated microspheres had less surface micropores compared to PVA based preparations. The drug release behaviour from microspheres suspended in phosphate buffered saline exhibited a biphasic pattern. The amount of drug release was much higher initially (approximately 25%), followed by a constant slow release profile for a 30 days period of study. This chitosan coated PLA/PLGA microsphere formulation may have potential for the targeted delivery of 5-FU to treat cerebral tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038121     DOI: 10.1080/026520400417676

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  6 in total

1.  Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery.

Authors:  Tapan Kumar Giri; Chhatrapal Choudhary; Amit Alexander; Hemant Badwaik; Dulal Krishna Tripathi
Journal:  Saudi Pharm J       Date:  2012-05-26       Impact factor: 4.330

2.  Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.

Authors:  Sofia Ahmed; Muhammad Ali Sheraz; Ihtesham Ur Rehman
Journal:  AAPS PharmSciTech       Date:  2013-04-27       Impact factor: 3.246

3.  Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice.

Authors:  Mingrong Cheng; Zheng Liu; Tao Wan; Bing He; Bingbing Zha; Jiang Han; Houxiang Chen; Fengxiao Yang; Qing Li; Wei Wang; Hongzhi Xu; Tao Ye
Journal:  Cancer Biol Ther       Date:  2012-09-06       Impact factor: 4.742

4.  N-Succinyl-chitosan nanoparticles coupled with low-density lipoprotein for targeted osthole-loaded delivery to low-density lipoprotein receptor-rich tumors.

Authors:  Chun-ge Zhang; Qiao-ling Zhu; Yi Zhou; Yang Liu; Wei-liang Chen; Zhi-Qiang Yuan; Shu-di Yang; Xiao-feng Zhou; Ai-jun Zhu; Xue-nong Zhang; Yong Jin
Journal:  Int J Nanomedicine       Date:  2014-06-13

5.  Current progress on bio-based polymers and their future trends.

Authors:  Ramesh P Babu; Kevin O'Connor; Ramakrishna Seeram
Journal:  Prog Biomater       Date:  2013-03-18

Review 6.  Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems.

Authors:  José L Arias
Journal:  Molecules       Date:  2008-10-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.